Hadassah

Peace in Sight: An Israeli, Palestinian, and Hadassah Australia Collaboration

Friday, Jan 13 2017

Peace in Sight participant.

St. John of Jerusalem Eye Hospital, in collaboration with Hadassah Medical Organization, has received a €500,000 grant from the European Union to establish a genetic research unit to serve the Palestinian communities.

St. John, established in 1885, has built a reputation for fine ophthalmic care in the region. The primarily Palestinian population that it serves faces many health challenges, not the least being serious eye disease, much of it driven by the very high incidence of consanguineous marriages.

The main missions of Peace in Sight are to:

·       Train a Palestinian ophthalmologist from St. John at Hadassah in molecular genetics and clinical management

·       Study in depth 100-200 Palestinians with hereditary eye diseases to identify the most common ones

·       Establish a fully functional Genetic Disease Laboratory at St John

·       Collect samples from recruited Palestinians and identify the most common genetic patterns of inherited ocular diseases in the Palestinian population

·       Provide counseling for prevention of disease transmission

·       Explore novel treatment modalities, including gene and cell-based therapies

·       Increase awareness of targeted beneficiaries on an individual basis and

·       Facilitate access or travel permits with the Israeli Civil Administration.

The grant of €500,000 for the three-year Peace in Sight project constitutes approximately 80 percent of the total project cost. Hadassah Australia is seeking to raise $50,000 to assist with the remainder. Toward that goal, Hadassah Australia recently held a luncheon at the RANZCO (Royal Australian and New Zealand College of Ophthalmologists) Conference to raise awareness and funds for Peace in Sight, which brought in over $10,000 for the project. Follow-up letters have also been sent out to ophthalmologists who could not attend to raise additional funds.

Ron Finkel, President of Hadassah Australia, reports: “We will be pursuing this campaign through the first quarter of 2017, culminating with the visit to Sydney in late March by Prof. Koby Pe’er, head of the Department of Ophthalmology at Hadassah.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More